SMCO Hilton Small-MidCap Opportunity ETF

Expense Ratio
0.55%
Dividend
0.98%
Previous close
$27.59
Est. 12 months change
+17.53%
Projected Price
$32.43

Profitability Metrics

Return on Equity (ROE)
15.66%
Return on Assets (ROA)
6.09%
Return on Invested Capital (ROIC)
11.40%
Weighted Average Cost of Capital (WACC)
8.79%
ROIC - WACC
2.61%
Updated : 2026-04-04 08:25 ET

Valuation Metrics

P/E Ratio
24.07
Forward P/E
19.59
PEG Ratio
2.54
Debt Current Ratio
1.97

Growth & Cash Flow

Gross Margin
43.24%
Operating Margin
15.25%
FCF Margin
13.19%
TTM Revenue Growth
11.98%
Projected 12M EPS Growth
22.82%

Price Change

Price % from 50 SMA
-2.02%
Price % from 200 SMA
1.81%
6 Months
1.63%
1 Year
14.47%
2 Years
16.94%
The above metrics represent weighted averages, calculated using each stock's individual value weighted by its proportion of ETF holdings.

Top 10 Holdings

Stock TickerWeight
EQT2.85%
CLH2.78%
IDA2.52%
DY2.48%
TDY2.46%
CFR2.38%
NVT2.31%
PRIM2.29%
CIEN2.23%
BJ2.15%

ETF Analysis

Fund Overview

Hilton Small-MidCap Opportunity ETF (SMCO) currently reports 62 stock positions (subject to change), placing it in the balanced in breadth range by holdings breadth. The top line-up is EQT (2.85%), CLH (2.78%), IDA (2.52%), with EQT as the largest single weight at 2.85%. Together, the top three holdings account for 8.15%, which reflects a construction where the top positions carry meaningful but not outsized influence on aggregate returns. In aggregate, the construction reflects a balance between directional conviction and the diversification benefits that come from a broader holding set.

Profitability & Capital Efficiency

On the question of capital productivity, ROIC is 11.40%, WACC is 8.79%, and the economic spread is 2.61%. On balance, returns on capital just exceed funding costs, implying limited but real value creation at the margin. Supporting metrics show ROE at 15.66% and ROA at 6.09%, a combination that helps frame whether profitability strength is broad enough to hold through different market conditions. Taken together, the return profile suggests a portfolio that is value-creative but with less room for execution slippage.

Valuation

Assessed on a multiple basis, trailing P/E of 24.07, forward P/E of 19.59, PEG of 2.54. Forward P/E tracks closely with trailing P/E — a sign that the market sees the current earnings run rate as a reasonable baseline going forward. At this PEG level, the valuation case rests more on quality, scarcity, or market leadership than on earnings growth alone. The portfolio carries an aggregate current ratio of 1.97, consistent with adequate near-term liquidity management. Overall, the valuation setup reads as a balance between expected growth and execution risk, with liquidity acting as an important stabilizer if macro conditions become less favorable.

Margins & Cash Generation

The margin stack reads as follows: gross margin sits at 43.24%, operating margin at 15.25%, and free cash flow margin at 13.19%. The gross margin reading points to holdings with solid but not outsized pricing power relative to direct costs. The portfolio's operating margins are solid, pointing to holdings where overhead management is a relative strength. FCF margins are in a reasonable range, though there is room for improvement in how efficiently revenues convert to free cash. The margin profile is a mixed read — some holdings are clearly well-run, but the aggregate numbers point to a basket that is not uniformly high-quality.

Growth & Forward Outlook

The forward view combines two signals: the estimated 12-month price change of 17.71%, where analyst assumptions support a moderate upside case if execution remains steady, while TTM revenue growth of 11.98% suggesting the portfolio's holdings are growing revenues at a measured, sustainable pace. The projected 12-month EPS growth rate of 22.8% is a standout component of the forward case — meaningful earnings expansion at this scale typically warrants attention from growth-oriented investors. One metric reflects operational reality, the other market expectation — both are useful inputs, but neither should be read in isolation. The interaction between revenue execution and analyst repricing will ultimately determine how closely realized returns track current expectations. The estimated 12-month price change is a weighted composite of analyst price target estimates adjusted by each holding's ETF weight, sourced from publicly available data, and should not be interpreted as a reliable prediction of future performance.

Conclusion

Buy

The overall evidence base is constructive, with more signals pointing up than down and no obvious structural impairment to the forward case.

These findings are based solely on the metrics presented and do not constitute an investment recommendation. Always perform your own due diligence before committing capital.